Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV
Open Access
- 1 December 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 5 (12)
Abstract
Background: Compared to uninfected adults, HIV ‐infected adults on antiretroviral therapy are at increased risk of cardiovascular disease. Given the increase in T‐cell dysfunction, inflammation, and coagulation in HIV infection, microvascular dysfunction is thought to contribute to this excess cardiovascular risk. However, the relationships between these variables remain undefined. Methods and Results: This was a cross‐sectional study of 358 HIV ‐infected adults from the SCOPE cohort. Macrovascular endothelial function was assessed using flow‐mediated dilation of the brachial artery and microvascular function by reactive hyperemia. T‐cell phenotype was determined by flow cytometry. Plasma markers of inflammation (tumor necrosis factor‐α, interleukin‐6, high‐sensitivity C‐reactive protein, sCD 14) and coagulation (fibrinogen, D‐dimer) were also measured. In all HIV + subjects, markers of inflammation (tumor necrosis factor‐α, high‐sensitivity C‐reactive protein), coagulation (D‐dimer) and T‐cell activation ( CD 8+ PD 1+, CD 4+interferon+cytomegalovirus‐specific) were associated with worse reactive hyperemia after adjusting for traditional cardiovascular risk factors and co‐infections. In treated and suppressed subjects, tumor necrosis factor‐α and CD 8+ PD 1+ cells remained associated with worse reactive hyperemia after adjustment. Compared to the untreated subjects, CD 8+ PD 1+ cells were increased in the virally suppressed group. Reactive hyperemia was predictive of flow‐mediated dilation. Conclusions: CD 8+ PD 1+ cells and tumor necrosis factor‐α were associated with microvascular dysfunction in all HIV + subjects and the treated and suppressed group. Additionally, D‐dimer, high‐sensitivity C‐reactive protein, sCD ‐14, and interleukin‐6 were associated with microvascular dysfunction in all HIV + subjects. Although T‐cell dysfunction, inflammation, and microvascular dysfunction are thought to play a role in cardiovascular disease in HIV , this study is the first to look at which T‐cell and inflammatory markers are associated with microvascular dysfunction in HIV ‐infected individuals.Keywords
This publication has 61 references indexed in Scilit:
- Immunologic Basis of Cardiovascular Disease in HIV-Infected AdultsThe Journal of Infectious Diseases, 2012
- Sudden Cardiac Death in Patients With Human Immunodeficiency Virus InfectionJACC, 2012
- Cytomegalovirus Immunoglobulin G Antibody Is Associated With Subclinical Carotid Artery Disease Among HIV-Infected WomenThe Journal of Infectious Diseases, 2012
- T cell activation predicts carotid artery stiffness among HIV-infected womenAtherosclerosis, 2011
- Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral TherapyThe Journal of Infectious Diseases, 2011
- Risk of Heart Failure With Human Immunodeficiency Virus in the Absence of Prior Diagnosis of Coronary Heart DiseaseArchives of internal medicine (1960), 2011
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV InfectionThe Journal of Infectious Diseases, 2011
- T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected WomenThe Journal of Infectious Diseases, 2011
- Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study CohortJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjectsJournal of Experimental Medicine, 2005